Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue SUPPL. 2, 2008, Pages

  Morrissey, Ian ^a   Maher, Kirsty ^a   Williams, Laura ^a   Shackcloth, Jemma ^a   Felmingham, David ^a   Reynolds, Rosy ^b  

^a Quotient Bioresearch Limited   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Breakpoint; MIC; Resistance; Surveillance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFACLOR; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; ERTAPENEM; ERYTHROMYCIN; FROPENEM; GEMIFLOXACIN; LEVOFLOXACIN; MINOCYCLINE; MOXIFLOXACIN; PENICILLIN G; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM;

AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IRELAND; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PREVALENCE; RESPIRATORY TRACT INFECTION; UNITED KINGDOM;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; GREAT BRITAIN; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; SENTINEL SURVEILLANCE;

EID: 54349102795     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn356     Document Type: Article

References (36)

1. Pfaller MA, Ehrhardt AF, Jones RN. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study. Am J Med 2001; 111 Suppl 9A: 4S-12S.
2. Anon. Chemotherapy of bronchitis. BMJ 1970; 1: 125-6.
3. Finland M, Garner C, Wilcox C et al. Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrob Agents Chemother 1976; 9: 274-87.
4. Gordon RC, Thompson TR, Stevens LI et al. In vitro susceptibility of Haemophilus influenzae to eight antibiotics. Antimicrob Agents Chemother 1974; 6: 114-5.
5. Thornsberry C, Kirven LA. Antimicrobial susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother 1974; 6: 620-4.
6. Jorgensen JH, Jones PM. Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother 1975; 7: 186-90.
7. Howard AJ, Hince CJ, Williams JD. Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. BMJ 1978; 1: 1657-60.
8. Philpott-Howard J, Williams JD. Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: Report of study group. BMJ 1982; 284: 1597-9.
9. Powell M, Koutsia-Carouzou C, Voutsinas D et al. Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986. BMJ 1987; 295: 176-9.
10. Powell M, Fan YS, Seymour A et al. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother 1992; 29: 547-54.
11. Felmingham D, Robbins MJ, Dencer C et al. Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens. J Antimicrob Chemother 1996; 38: 747-51.
12. Felmingham D, Robbins MJ, Tesfaslasie Y et al. Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season. J Antimicrob Chemother 1998; 41: 411-5.
13. Catlin BW. Branhamella catarrhalis: An organism gaining respect as a pathogen. Clin Microbiol Rev 1990; 3: 293-320.
14. Barber M, Waterworth PM. Antibacterial activity of the penicillins. BMJ 1962; 1: 1159-62.
15. Malmvall B-E, Brorsson J-E, Johnsson J. In vitro sensitivity to penicillin V and β-lactamase production of Branhamella catarrhalis. J Antimicrob Chemother 1977; 3: 374-5.
16. Brorson JE, Martinell J, Wilske H. Branhamella catarrhalis: antibiotic susceptibility and β-lactamase production. J Antimicrob Chemother 1981; 7: 208-9.
17. McLeod DT, Ahmad F, Power JT et al. Bronchopulmonary infection due to Branhamella catarrhalis. BMJ 1983; 287: 1446-77.
18. McLeod DT, Ahmad F, Capewell S et al. Increase in bronchopulmonary infection due to Branhamella catarrhalis. BMJ 1986; 292: 1103-5.
19. Winstanley TG, Spencer RC. Moraxella catarrhalis antibiotic susceptibility with special reference to trimethoprim. J Antimicrob Chemother 1986; 18: 425-31.
20. Sweeney KG, Verghese A, Needham CA. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother 1985; 27: 499-502.
21. Alvarez S, Jones M, Holtsclaw-Berk S et al. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother 1985; 27: 646-7.
22. Powell M, McVey D, Kassim MH et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J Antimicrob Chemother 1991; 28: 249-59.
23. Fung CP, Powell M, Seymour A et al. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. J Antimicrob Chemother 1992; 30: 47-55.
24. Doern GV, Jones RN, Pfaller MA et al. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother 1999; 43: 385-9.
25. Reynolds R, Hope R, Williams L et al. Survey, laboratory, and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 2008; 62 Suppl 2: Ii15-28.
26. Reynolds R, Lambert P, Burton P et al. Analysis, power and design of antibiotic resistance surveillance studies taking account of inter-centre variation and turnover. J Antimicrob Chemother 2008; 62 Suppl 2: Ii29-39.
27. http://www.bsac.org.uk/susceptibility_testing/ bsac_standardized_disc_susceptibility_method.cfm (24 January 2008, date last accessed).
28. Woodhead M, Macfarlane J, BTS CAP Guidelines Committee. Local antibiotic guidelines for adult community-acquired pneumonia (CAP): A survey of UK hospital practice in 1999. J Antimicrob Chemother 2000; 46: 141-3.
29. Marchese A, Schito GC. Recent findings from multinational resistance surveys: Are we 'PROTEKTed' from resistance? Int J Antimicrob Agents 2007; 29 Suppl 1: S2-S5.
30. Fluit AC, Florijn A, Verhoef J et al. Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/3. J Antimicrob Chemother 2000; 45: 191-203.
31. Gracia M, Díaz C, Coronel P et al. Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005-06: Results of the cefditoren Surveillance Study. J Antimicrob Chemother 2008; 61: 1180-1.
32. Alpuche C, Garau J, Lim V. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens. Int J Antimicrob Agents 2007; 30S: S135-8.
33. Critchley IA, Brown SD, Traczewski MM et al. National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem Surveillance Study. Antimicrob Agents Chemother 2007; 51: 4382-9.
34. Srifuengfung S, Chayakulkeeree M, Chokephaibulkit K et al. Five-year study of antimicrobial susceptibility and beta-lactamase production in Haemophilus influenzae. Southeast Asian J Trop Med Public Health 2007; 38: 732-6.
35. Hoban D, Felmingham D. The PROTEKT surveillance study: Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50 Suppl 2: 49-59.
36. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbial Rev 2007; 20: 368-9.